Overview

A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2019-03-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether an Automated Insulin Delivery (AID) System is safe to use and functions as intended with personalized basal insulin rates and when basal insulin rates are increased.
Phase:
N/A
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc